Claude 3 Opus — Clinical LLM Test: Breast Cancer Case
🎯 核心理念 / Core Philosophy
AI 是医生的辅助工具，而非替代者。我们利用 AI 协助医生对照临床指南、发现病例中可能漏掉的疑点，并指向指南的具体章节和页码。最终治疗决策仍由医生基于循证医学做出。
Anthropic's flagship model tested on a post-operative breast cancer case. Results coming soon.
Why Claude 3 Opus?
Claude 3 Opus is Anthropic's most capable model for complex reasoning tasks. We're testing it on the same breast cancer case used across our clinical LLM benchmark series.
Test Methodology
- Case: Post-operative breast cancer (60F, pT1aN0M0 IA)
- Input: De-identified outpatient case screenshot
- Scoring: 16-item rubric vs 2026 CBCS guidelines (max 100)
- Runs: 20 iterations to measure stability
Results
Results tab will be available once data collection is complete.
Comparison with Other Models
Claude 3 Opus will be compared against DeepSeek V4, ChatGLM 5.2, Kimi K2.6, and Doubao in our unified ranking.
FAQ
When will results be published?
We're collecting 20 runs. Expected completion: August 2026.
How does Claude 3 Opus compare to GPT-4?
Both are tested using identical methodology. Results will be published in our unified ranking.